Zylem Biosciences
PrivateLast Round
VC Round
Apr 1, 2023
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Zylem Biosciences operates in Healthcare & Life Sciences and is based in Chicago, Illinois. Its latest recorded funding round was a VC Round in April 2023.
Zylem Biosciences is a biotechnology company developing targeted medicines based on its novel platform technology, which is a structural analog of natural high-density lipoprotein (HDL).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Fashion & Beauty
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Zylem Biosciences Comparables
Compare Zylem Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Abionyx Pharma SA | 73% | |
| CSL Ltd | 60% | |
| Exicure, Inc. | 46% |
For institutional investors. Book with your work email.
Zylem Biosciences Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Zylem Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| FSB Companies | VC Round |
| Portal Innovations | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 59% MoM.
- Jul 27, 2026
Monthly visitors increased 37% MoM.
For institutional investors. Book with your work email.
Zylem Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Zylem Biosciences's valuation, stock price, and market status.
Is Zylem Biosciences a public or private company?
Zylem Biosciences is a private company.
What is the current stock price of Zylem Biosciences?
Zylem Biosciences is a private company, so its shares have no public market price. Caplight tracks Zylem Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Zylem Biosciences worth (valuation)?
Valuation information for Zylem Biosciences is not publicly available.
Can I buy Zylem Biosciences stock?
Zylem Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Zylem Biosciences's last funding round?
Zylem Biosciences's most recent funding round was VC Round on April 1, 2023.
Who are the main investors in Zylem Biosciences?
Key investors in Zylem Biosciences include FSB Companies, Portal Innovations.
Will Zylem Biosciences IPO soon?
No public IPO plans have been announced for Zylem Biosciences.
How can I track Zylem Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Zylem Biosciences's shares on secondary markets.